FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding.

FcγRIIB allosterically conformational change human immunology in-situ 2D binding kinetics inflammation membrane receptor molecular biophysics single-nucleotide polymorphism structural biology systemic lupus erythematosus

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
25 07 2019
Historique:
received: 22 03 2019
accepted: 25 07 2019
pubmed: 26 7 2019
medline: 8 2 2020
entrez: 26 7 2019
Statut: epublish

Résumé

FcγRIIB binding to its ligand suppresses immune cell activation. A single-nucleotide polymorphic (SNP) change, I232T, in the transmembrane (TM) domain of FcγRIIB loses its suppressive function, which is clinically associated with systemic lupus erythematosus (SLE). Previously, we reported that I232T tilts FcγRIIB's TM domain. In this study, combining with molecular dynamics simulations and single-cell FRET assay, we further reveal that such tilting by I232T unexpectedly bends the FcγRIIB's ectodomain toward plasma membrane to allosterically impede FcγRIIB's ligand association. I232T substitution reduces in situ two-dimensional binding affinities and association rates of FcγRIIB to interact with its ligands, IgG1, IgG2 and IgG3 by three to four folds. This allosteric regulation by an SNP provides an intrinsic molecular mechanism for the functional loss of FcγRIIB-I232T in SLE patients.

Identifiants

pubmed: 31343409
doi: 10.7554/eLife.46689
pii: 46689
pmc: PMC6711707
doi:
pii:

Substances chimiques

FCGR2B protein, human 0
Immunoglobulin G 0
Mutant Proteins 0
Receptors, IgG 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Basic Research Program of China
ID : 2015CB910800
Pays : International
Organisme : National Natural Science Foundation of China
ID : 31470900
Pays : International
Organisme : National Natural Science Foundation of China
ID : 31522021
Pays : International
Organisme : National Natural Science Foundation of China
ID : 11672317
Pays : International
Organisme : National Natural Science Foundation of China
ID : 11772348
Pays : International
Organisme : Fundamental Research Funds for the Central Universities
ID : 2015XZZX004-32
Pays : International
Organisme : Natural Basic Research Program of China
ID : 2015CB910800
Pays : International
Organisme : Natural Science Foundation of China
ID : 31470900
Pays : International
Organisme : Natural Science Foundation of China
ID : 31522021
Pays : International
Organisme : Natural Science Foundation of China
ID : 11672317
Pays : International
Organisme : Natural Science Foundation of China
ID : 11772348
Pays : International
Organisme : Fundamental Research Founds for the Central Universities
ID : 2015XZZX004-32
Pays : International

Informations de copyright

© 2019, Hu et al.

Déclaration de conflit d'intérêts

WH, YZ, XS, TZ, LX, HX, ZL, WL, JL, WC No competing interests declared

Références

Mol Immunol. 2004 Jul;41(6-7):599-613
pubmed: 15219998
Cell. 2014 Apr 10;157(2):357-368
pubmed: 24725404
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
J Biol Chem. 2004 Oct 22;279(43):44915-23
pubmed: 15299021
Ann N Y Acad Sci. 2010 Jan;1183:69-88
pubmed: 20146709
J Biol Chem. 2000 Apr 7;275(14):10235-46
pubmed: 10744709
Nat Med. 2005 Oct;11(10):1056-8
pubmed: 16170323
Nat Commun. 2015 Oct 06;6:8552
pubmed: 26440273
Cell. 2008 Nov 14;135(4):702-13
pubmed: 19013279
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7881-5
pubmed: 20385827
J Comput Chem. 2014 Oct 15;35(27):1997-2004
pubmed: 25130509
Proc Natl Acad Sci U S A. 2007 Apr 24;104(17):7169-74
pubmed: 17435165
Mol Cell. 2019 Mar 7;73(5):1015-1027.e7
pubmed: 30711376
J Immunol. 2014 Jan 1;192(1):35-9
pubmed: 24285839
J Immunol. 2014 Jun 1;192(11):5179-91
pubmed: 24790152
Hum Mol Genet. 2005 Oct 1;14(19):2881-92
pubmed: 16115811
Biophys J. 1998 Sep;75(3):1553-72
pubmed: 9726957
Tissue Antigens. 2004 Jan;63(1):21-7
pubmed: 14651519
Tissue Antigens. 2003 May;61(5):374-83
pubmed: 12753656
Arthritis Rheum. 2002 May;46(5):1242-54
pubmed: 12115230
Immunol Lett. 1996 Dec;54(2-3):77-82
pubmed: 9052858
J Comput Chem. 2005 Dec;26(16):1781-802
pubmed: 16222654
J Immunol. 2010 Feb 15;184(4):1977-89
pubmed: 20083655
J Phys Chem B. 1998 Apr 30;102(18):3586-616
pubmed: 24889800
Nat Immunol. 2014 Aug;15(8):707-16
pubmed: 25045879
J Exp Med. 2016 Nov 14;213(12):2707-2727
pubmed: 27799621
Nature. 2010 Apr 8;464(7290):932-6
pubmed: 20357766
Nat Rev Immunol. 2010 May;10(5):328-43
pubmed: 20414206

Auteurs

Wei Hu (W)

Department of Neurobiology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Yong Zhang (Y)

Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Xiaolin Sun (X)

Beijing Key Laboratory for Rheumatism and Immune Diagnosis (BZ0135), Department of Rheumatology and Immunology, Peking-Tsinghua Center for Life Sciences, Peking University People's Hospital, Beijing, China.

Tongtong Zhang (T)

Department of Neurobiology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Liling Xu (L)

MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing, China.

Hengyi Xie (H)

MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing, China.

Zhanguo Li (Z)

Beijing Key Laboratory for Rheumatism and Immune Diagnosis (BZ0135), Department of Rheumatology and Immunology, Peking-Tsinghua Center for Life Sciences, Peking University People's Hospital, Beijing, China.

Wanli Liu (W)

MOE Key Laboratory of Protein Sciences, Center for Life Sciences, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, School of Life Sciences, Beijing Key Lab for Immunological Research on Chronic Diseases, Institute for Immunology, Tsinghua University, Beijing, China.

Jizhong Lou (J)

Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
University of Chinese Academy of Sciences, Beijing, China.

Wei Chen (W)

Department of Neurobiology and Department of Cardiology of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Key Laboratory for Biomedical Engineering of Ministry of Education, State Key Laboratory for Modern Optical Instrumentation, College of Biomedical Engineering and Instrument Science, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH